CANTEL MEDICAL CORP. (NYSE:CMD) changed -0.55% to recent value of $70.4. The stock transacted 284708 shares during most recent day however it has an average volume of 261.44K shares. It spotted trading -25.00% off 52-week high price. On the other end, the stock has been noted 10.92% away from the low price over the last 52-weeks.
On Oct. 2, 2019, CANTEL MEDICAL CORP. (NYSE:CMD) released that it has completed its previously announced acquisition of Hu-Friedy Mfg. Co LLC, a 111-year-old global leading manufacturer of instruments and instrument reprocessing workflow systems serving the dental industry. The purchase price payable at closing for the acquisition consisted of 751,471 shares of Cantel common stock and $665 million in cash, subject to customary adjustments. As previously disclosed, the transaction structure is anticipated to result in tax benefits to Cantel presently valued at more than $100 million.
About Cantel Medical Corp.
Cantel is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. The Company’s products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, Cantel provides technical service for its products.
CMD has a gross margin of 46.90% and an operating margin of 9.10% while its profit margin remained 6.00% for the last 12 months. Its earnings per share (EPS) expected to touch remained -31.20% for this year while earning per share for the next 5-years is expected to reach at 2.75%.
The company has 42M of outstanding shares and 36.93M shares were floated in the market. According to the most recent quarter its current ratio was 2.3 that represents company’s ability to meet its current financial obligations. The price moved ahead of -13.11% from the mean of 20 days, -17.87% from mean of 50 days SMA and performed -8.25% from mean of 200 days price. Company’s performance for the week was -6.13%, -15.16% for month and YTD performance remained -5.44%.
Robert Holton is an author, journalist and CEO of the website. He has more than 5 years of experience in institutional investment markets, including fixed income, equities, derivatives and real estate. He has a Bachelor in Business Administration with a major in Finance. He bought his first stocks in a private business at age 15 and made his first public stock trade at 23. Robert has always been interested in the stock market and how it behaves.
Robert reports about Finance news category. As the dad of two children, he’s made saving money and investing for them a high priority. Over many years of investing, he has made some wise choices and he’s made many mistakes. But he’s learned from both. Mr. Robert observations and experience give him the insight to stock market patterns and the investor behaviors that create them.
Address: 1149 Plainfield Avenue, Edwards, New York
Email: Robe[email protected]
Zip Code: 18042
Contact number: 978-661-4371